Novocure Ltd
NVCR
$14.58+2.53%
End of day · as of Oct 11, 2026, 10:46 PM ET
Mkt cap
$1.99B
EV/Sales
3.19
P/E ratio
N/A
FY2025 Revenue
$655.35M
EPS (TTM)
$-1.30
Gross Margin (FY2025)
74.54%
Profit Margin (FY2025)
-20.79%
Beta
0.92
Div yield
N/A
Sector
Healthcare
Novocure Ltd (NVCR) is a medical devices company listed on US.
Latest reported NVCR revenue for 2025-12-31 was $655.4M. Net income was -$136.2M. Revenue was up 400.3% from 2022-09-30 to 2025-12-31. NVCR currently screens at market cap $1.99B.
Use this NVCR research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full NVCR income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Novocure Ltd (NVCR) is a medical devices company in the Healthcare sector.
Latest cached Novocure Ltd (NVCR) revenue for Dec 31, 2025 was $655.4M. Net income was -$136.2M. Statements: https://lician.com/financials/nvcr
Novocure Ltd (NVCR) market capitalization is $1.99B on the latest cached snapshot.
Novocure Ltd (NVCR) cached previous close $14.22; day range $14.14 – $14.78; volume 1,021,963. Session quote: https://lician.com/quote/nvcr
Novocure Ltd (NVCR) latest cached earnings event is "NVCR earnings" on Jul 23, 2026. Earnings calendar: https://lician.com/earnings
The latest cached NVCR filing is 8-K · Oct 1, 2026. Filings: https://lician.com/sec/nvcr